Michael T. Serzan - Department of Medical Oncology, Dana-Farber Cancer Institute

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 23 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Advanced Renal Cell Cancer Combination Immunotherapy Clinical Trial (ARCITECT; HCRN GU 22-587)

Michael Thomas Serzan,Opeyemi Jegede, Robert S. Alter, Mehmet Asim Bilen,David A. Braun,David Johnson Einstein,Naomi B. Haas,Daniel Herchenhorn, Jennifer King, Karie Runcie,Jeffrey A. Sosman,Cora N. Sternberg, Yuanquan (Aaron) Yang,Sabina Signoretti,Toni K. Choueiri,Michael B. Atkins

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

引用0浏览0引用

Clinical Outcomes of Immune Checkpoint Inhibitors in Unique Cohorts Underrepresented in Clinical Trials

Neil J. Shah,Alexandra Della Pia,Tianmin Wu,Aquino Williams,Melinda Weber,Brittany Sinclaire,Elli Gourna Paleoudis,Adil Alaoui,Shaked Lev-Ari,Shari Adams, Jordan Kaufman, Sahil B. Parikh,Emily Tonti,Eric Muller,Michael Serzan, Divya Cheruku, Albert Lee, Aishwarya Sridhar, Benjamin (Thor) Perrin Hee,Jaeil Ahn,Andrew Pecora, Andrew Ip,Michael B. Atkins

CANCERSno. 12 (2024)

引用0浏览0WOS引用

Expanding the Morphologic and Clinical Spectrum of Merlin-Deficient Renal Cell Carcinoma

Michelle Hirsch,Kiril Trpkov, Sean Williamson, Katrina Collins,Andres Acosta, Stephanie Siegmund,Toni Choueiri,Michael Serzan,Natalie Rizzo

LABORATORY INVESTIGATIONno. 3 (2024): S960-S960

引用0浏览0引用

Pilot Study of an Implantable Microdevice Forin Vivo Evaluation of Drug Response in Renal Cell Carcinoma (NCT05700461)

Wenxin Xu,Sharath Bhagavatula, Clara Steiner, Caiwei Zhong,Matthew Mossanen,Steven Chang,Michelle Hirsch,Sebastian Ahn, Destiny Matthew,Stephanie Berg,Michael Serzan,Bradley McGregor,Nobuhiko Hata,Srinivas Viswanathan, Stuart Silverman,Oliver Jonas,Toni Choueiri

ONCOLOGIST (2024): S14-S15

引用0浏览0引用

First-Line Treatment for Intermediate and Poor Risk Advanced or Metastatic Clear Cell Renal Cell Carcinoma

Michael T. Serzan,Wenxin Xu,Stephanie A. Berg

Hematology/oncology clinics of North Americano. 5 (2023): 951-964

引用0浏览0WOS引用

Adjuvant therapy for patients with renal cell carcinoma following surgery: a focus on pembrolizumab

Michael Serzan,Michael B. Atkins

EXPERT REVIEW OF ANTICANCER THERAPY（2022）

引用2浏览0WOS引用

The Risk of Opportunistic Infections and the Role of Antibiotic Prophylaxis in Patients on Checkpoint Inhibitors Requiring Steroids

Neil J. Shah,Michael R. Cook,Tianmin Wu,Shaked Lev-Ari,Matthew J. Blackburn,Michael T. Serzan,Adil Alaoui,Jaeil Ahn,Michael B. Atkins

Journal of the National Comprehensive Cancer Networkno. 7 (2022): 800-807.e1

引用4浏览0WOS引用

Correction: Zhang Et Al. Association Between Body Mass Index and Immune-Related Adverse Events (iraes) among Advanced-Stage Cancer Patients Receiving Immune Checkpoint Inhibitors: A Pan-Cancer Analysis. Cancers 2021, 13, 6109

Dongyu Zhang,Neil J Shah,Michael Cook,Matthew Blackburn,Michael T Serzan,Shailesh Advani,Arnold L Potosky,Subha Madhavan,Anas Belouali,Michael B Atkins,Dejana Braithwaite

Cancers（2022）

引用1浏览0WOS引用

Andrew Ip, Shuo Wang, Divya Cheruku,Kanchi Krishnamurthy,Melinda Weber,Brittany Sinclaire,Elli Gourna Paleoudis,Adil Alaoui,Shaked Lev-Ari,Michael T. Serzan,Shari Adams, Jordan Kaufman, Sahil B. Parikh,Emily Tonti, Eric Muller,Aquino Williams, Jaeil Ahn,Andrew Pecora,Michael B. Atkins,Neil J. Shah

JOURNAL OF CLINICAL ONCOLOGYno. 15 (2021)

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn